Interactive tools: Colorectal Cancer Prognosis

Fluorouracil- (FU-) based adjuvant therapy is an established therapy for patients with resected high-risk colon cancer. This tool provides the results from a pooled analysis of 3302 patients from seven randomised trials and compares the magnitude of adjuvant therapy benefit across specific subgroups.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings